QuidelOrtho
QDEL
#3779
Rank
ยฃ2.06 B
Marketcap
ยฃ30.77
Share price
0.23%
Change (1 day)
-45.95%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

Revenue for QuidelOrtho (QDEL)

Revenue in 2024 (TTM): ยฃ2.25 Billion

According to QuidelOrtho's latest financial reports the company's current revenue (TTM ) is ยฃ2.17 Billion. In 2023 the company made a revenue of ยฃ2.35 Billion a decrease over the revenue in the year 2022 that were of ยฃ2.69 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for QuidelOrtho from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ2.25 B-3.98%
2023 ยฃ2.35 B-12.84%
2022 ยฃ2.69 B114.53%
2021 ยฃ1.25 B3.22%
2020 ยฃ1.21 B198.86%
2019 ยฃ0.40 B-0.86%
2018 ยฃ0.41 B100.22%
2017 ยฃ0.20 B32.34%
2016 ยฃ0.15 B17.33%
2015 ยฃ0.13 B12.63%
2014 ยฃ0.11 B10.5%
2013 ยฃ0.10 B10.36%
2012 ยฃ96.35 M-5.57%
2011 ยฃ0.10 B38.98%
2010 ยฃ73.41 M-27.68%
2009 ยฃ0.10 B16.12%
2008 ยฃ87.42 M47.11%
2007 ยฃ59.43 M9.8%
2006 ยฃ54.12 M1.12%
2005 ยฃ53.52 M32.26%
2004 ยฃ40.47 M-23.88%
2003 ยฃ53.16 M11.77%
2002 ยฃ47.56 M-5.76%
2001 ยฃ50.47 M11.51%
2000 ยฃ45.27 M
1998 ยฃ29.7 M7.73%
1997 ยฃ27.57 M21.7%
1996 ยฃ22.65 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.25 B-88.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.22 B 599.50%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.52 B 1,393.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.21 B-90.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.20 B 644.55%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.57 B 18.45%๐Ÿ‡บ๐Ÿ‡ธ USA